[1]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30. https://doi.org/10.3322/caac.21590
|
[2]
|
Farzaei, M.H., Bahramsoltani, R. and Rahimi, R. (2016) Phytochemicals as Adjunctive with Conventional Anticancer Therapies. Current Pharmaceutical Design, 22, 4201-4218. https://doi.org/10.2174/1381612822666160601100823
|
[3]
|
Helms, S. (2004) Cancer Prevention and Therapeutics: Panax Ginseng. Alternative Medicine Review, 9, 259-274.
|
[4]
|
Leung, K.W. and Wong, A.S. (2010) Pharmacology of Ginsenosides: A Literature Review. Chinese Medicine, 5, 20. https://doi.org/10.1186/1749-8546-5-20
|
[5]
|
Juyeon, H., Seungyeon, L., Hyunkyung, L., Dawoon, J., Sungbin, P. and Jung, K.S. (2018) Genome-Wide Methylation Analysis Identifies NOX4 and KDM5A as Key Regulators in Inhibiting Breast Cancer Cell Proliferation by Ginsenoside Rg3. American Journal of Chinese Medicine, 46, 1333-1355.
|
[6]
|
Zhao, L., Liu, S., Xu, J., Li, W., Duan, G., Wang, H., et al. (2017) A New Molecular Mechanism Underlying the EGCG-Mediated Autophagic Modulation of AFP in HepG2 Cells. Cell Death & Disease, 8, e3160. https://doi.org/10.1038/cddis.2017.563
|
[7]
|
Sun, H.Y., Lee, J.H., Han, Y.S., Yoon, Y.M. and Sang, H.L. (2016) Pivotal Roles of Ginsenoside Rg3 in Tumor Apoptosis through Regulation of Reactive Oxygen Species. Anticancer Research, 36, 4647. https://doi.org/10.21873/anticanres.11015
|
[8]
|
Shan, X., Fu, Y.S., Aziz, F., Wang, X.Q., Yan, Q. and Liu, J.W. (2014) Ginsenoside Rg3 Inhibits Melanoma Cell Proliferation through Down-Regulation of Histone Deacetylase 3 (HDAC3) and Increase of p53 Acetylation. PLoS ONE, 9, e115401. https://doi.org/10.1371/journal.pone.0115401
|
[9]
|
Shan, X., et al. (2015) Ginsenoside Rg3-Induced EGFR/MAPK Pathway Deactivation Inhibits Melanoma Cell Proliferation by Decreasing FUT4/LeY Expression. International Journal of Oncology, 46, 1667-1676. https://doi.org/10.3892/ijo.2015.2886
|
[10]
|
Jiang, Z., Yang, Y., Yang, Y., Zhang, Y., Yue, Z., Pan, Z., et al. (2017) Ginsenoside Rg3 Attenuates Cisplatin Resistance in Lung Cancer by Downregulating PD-L1 and Resuming Immune. Biomedicine & Pharmacotherapy, 96, 378-383. https://doi.org/10.1016/j.biopha.2017.09.129
|
[11]
|
Hu, Q., Li, L., Zou, X., Xu, L. and Yi, P. (2018) Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4alpha/WNT5A Pathway in Gastric Carcinoma. Frontiers in Pharmacology, 9, 1150. https://doi.org/10.3389/fphar.2018.01150
|
[12]
|
Ge, G., Yan, Y. and Cai, H. (2017) Ginsenoside Rh2 Inhibited Proliferation by Inducing ROS Mediated ER Stress Dependent Apoptosis in Lung Cancer Cells. Biological & Pharmaceutical Bulletin, 40, 2117-2124. https://doi.org/10.1248/bpb.b17-00463
|
[13]
|
Liu, Y. (2016) nhibiting effect of ginsenoside Rh2 in vitro on nasopharynx cancer CSCs proliferation. Journal of Hainan Medical University.
|
[14]
|
Gao, Q. and Zheng, J. (2018) Ginsenoside Rh2 Inhibits Prostate Cancer Cell Growth through Suppression of microRNA-4295 That Activates CDKN1A. Cell Proliferation, 51, e12438. https://doi.org/10.1111/cpr.12438
|
[15]
|
Kim, M.Y., Yoo, B.C. and Cho, J.Y. (2014) Ginsenoside-Rp1-Induced Apolipoprotein A-1 Expression in the LoVo Human Colon Cancer Cell Line. Journal of Ginseng Research, 38, 251-255. https://doi.org/10.1016/j.jgr.2014.06.003
|
[16]
|
Zhang, E., Shi, H., Yang, L., Wu, X. and Wang, Z. (2017) Ginsenoside Rd Regulates the Akt/mTOR/p70S6K Signaling Cascade and Suppresses Angiogenesis and Breast Tumor Growth. Oncology Reports, 38, 359-367. https://doi.org/10.3892/or.2017.5652
|
[17]
|
Dai, Y., Wang, W., Sun, Q. and Tuohayi, J. (2018) Ginsenoside RG3 Promotes the Antitumor Activity of Gefitinib in Lung Cancer Cell Lines. Experimental and Therapeutic Medicine, 17, 953-959. https://doi.org/10.3892/etm.2018.7001
|
[18]
|
Aziz, F., Wang, X.Q., Liu, J.W., et al. (2016) Ginsenoside Rg3 Induces FUT4-Mediated Apoptosis in H. pylori CagA-Treated Gastric Cancer Cells by Regulating SP1 and HSF1 Expressions. Toxicology in Vitro, 31, 158-166. https://doi.org/10.1016/j.tiv.2015.09.025
|
[19]
|
Li, Y., Lu, J., Bai, F., Xiao, Y., Guo, Y. and Dong, Z. (2018) Ginsenoside Rg3 Suppresses Proliferation and Induces Apoptosis in Human Osteosarcoma. BioMed Research International, 2018, Article ID: 4306579. https://doi.org/10.1155/2018/4306579
|
[20]
|
Wang, J.H., Nao, J.F., Zhang, M. and He, P. (2014) 20(s)-ginsenoside Rg3 Promotes Apoptosis in Human Ovarian Cancer HO-8910 Cells through PI3K/Akt and XIAP Pathways. Tumor Biology, 35, 11985-11994. https://doi.org/10.1007/s13277-014-2497-5
|
[21]
|
Duan, Z., Wei, B., Deng, J., Mi, Y., Dong, Y., Zhu, C., et al. (2018) The Anti-Tumor Effect of Ginsenoside Rh4 in MCF-7 Breast Cancer Cells in Vitro and in Vivo. Biochemical & Biophysical Research Communications, 499, 482-487. https://doi.org/10.1016/j.bbrc.2018.03.174
|
[22]
|
Wu, Q., Deng, J., Fan, D., Duan, Z., Zhu, C., Fu, R., et al. (2017) Ginsenoside Rh4 Induces Apoptosis and Autophagic Cell Death through Activation of the ROS/JNK/p53 Pathway in Colorectal Cancer Cells. Biochemical Pharmacology, 148, 64-74. https://doi.org/10.1016/j.bcp.2017.12.004
|
[23]
|
Li, B., Zhao, J., Wang, C.Z., Searle, J., He, T.C., Yuan, C.S., et al. (2011) Ginsenoside Rh2 Induces Apoptosis and Paraptosis-Like Cell Death in Colorectal Cancer Cells through Activation of p53. Cancer Letters, 301, 185-192. https://doi.org/10.1016/j.canlet.2010.11.015
|
[24]
|
Qian, J., Jing, L., Jia, J.-G., Xin, J. and Qian, L.-Y. (2016) Ginsenoside-Rh2 Inhibits Proliferation and Induces Apoptosis of Human Gastric Cancer SGC-7901 Side Population Cells. Asian Pacific Journal of Cancer Prevention, 17, 1817-1821. https://doi.org/10.7314/APJCP.2016.17.4.1817
|
[25]
|
Wu, T.L., Tong, Y.C., Chen, I.H., Niu, H.S. and Cheng, J.T. (2018) Induction of Apoptosis in Prostate Cancer by Ginsenoside Rh2. Oncotarget, 9, 11109-11118. https://doi.org/10.18632/oncotarget.24326
|
[26]
|
Mao, Q., Zhang, P.H., Wang, Q. and Li, S.L. (2014) Ginsenoside F(2) Induces Apoptosis in Humor Gastric Carcinoma Cells through Reactive Oxygen Species-Mitochondria Pathway and Modulation of ASK-1/JNK Signaling Cascade in Vitro and in Vivo. Phytomedicine International Journal of Phytotherapy & Phytopharmacology, 21, 515-522. https://doi.org/10.1016/j.phymed.2013.10.013
|
[27]
|
Zhang, Y., Liu, Q.-Z., Xing, S.-P., et al. (2016) Inhibiting Effect of Endostar Combined with Ginsenoside Rg3 on Breast Cancer Tumor Growth in Tumor-Bearing Mice. Asia Pacific Journal of Tropical Medicine: English Version, 9, 180-183. https://doi.org/10.1016/j.apjtm.2016.01.010
|
[28]
|
Zheng, K., Li, Y., Wang, S., Wang, X., Liao, C., Hu, X., et al. (2016) Inhibition of Autophagosome-Lysosome Fusion by Ginsenoside Ro via the ESR2-NCF1-ROS Pathway Sensitizes Esophageal Cancer Cells to 5-Fluorouracil-Induced Cell Death via the CHEK1-Mediated DNA Damage Checkpoint. Autophagy, 12, 1593-1613. https://doi.org/10.1080/15548627.2016.1192751
|
[29]
|
Lv, D.L., Chen, L., Ding, W., Zhang, W., Wang, H.L., Wang, S., et al. (2018) Ginsenoside G-Rh2 Synergizes with SMI-4a in Anti-Melanoma Activity through Autophagic Cell Death. Chinese Medicine, 13, 11. https://doi.org/10.1186/s13020-018-0168-y
|
[30]
|
Liu, Z.H., Chen, D.L., Rong, J., Yi, C., Wei, X., Wang, F., et al. (2016) Ginsenoside Rh2-Induced Inhibition of Histone Deacetylase 6 Promotes K562 Cells Autophagy and Apoptosis in Vivo. China Journal of Chinese Materia Medica, 41, 700-704.
|
[31]
|
Sarkar, R., et al. (2014) Curcumin Augments the Efficacy of Antitumor Drugs Used in Leukemia by Modulation of Heat Shock Proteins via HDAC6. Journal of Environmental Pathology Toxicology & Oncology, 33, 247-263. https://doi.org/10.1615/JEnvironPatholToxicolOncol.2014010913
|
[32]
|
Chung, Y., Jeong, S., Choi, H.S., Ro, S. and Lee, J.S. (2018) Upregulation of Autophagy by Ginsenoside Rg2 in MCF-7 Cells. Animal Cells & Systems, 22, 382-389. https://doi.org/10.1080/19768354.2018.1545696
|
[33]
|
Yannan, L. and Daidi, F. (2018) Ginsenoside Rg5 Induces Apoptosis and Autophagy via Inhibition of PI3K/Akt Pathway against Breast Cancer in Mouse Model. Food & Function, 9, 5513-5527. https://doi.org/10.1039/C8FO01122B
|
[34]
|
Li, C., Dong, Y., Wang, L., Xu, G., Yang, Q., Tang, X., et al. (2019) Ginsenoside Metabolite Compound K Induces Apoptosis and Autophagy in Non-Small Cell Lung Cancer Cells via AMPK-mTOR and JNK Pathways. Biochemistry & Cell Biology, 97, 406-414. https://doi.org/10.1139/bcb-2018-0226
|
[35]
|
Ni, C., Li, Z. and Yang, H. (2014) Research Progress of Tumor Microenvironment and Tumor Cell Metastasis. Southwest Digestive Disease Academic Association Discussion and Guizhou Province Digestive Diseases and Digestive Endoscopy Academic Annual Meeting, Guizhou, 144-152.
|
[36]
|
Furusato, B., Mohamed, A., Uhlén, M. and Rhim, J.S. (2010) CXCR4 and Cancer. Pathology International, 60, 497-505. https://doi.org/10.1111/j.1440-1827.2010.02548.x
|
[37]
|
Chen, X.P., Qian, L.L., Jiang, H. and Chen, J.H. (2011) Ginsenoside Rg3 Inhibits CXCR4 Expression and Related Migrations in a Breast Cancer Cell Line. International Journal of Clinical Oncology, 16, 519-523. https://doi.org/10.1007/s10147-011-0222-6
|
[38]
|
Pan, Z., Dafeng, Y.E., Xie, X. and Chen, H. (2002) Antiangiogenesis of Ginsenoside Rg3 in Severe Combined Immunodeficient Mice with Human Ovarian Carcinoma. Chinese Journal of Obstetrics & Gynecology, 37, 227-230.
|
[39]
|
Xu, T.-M., Cui, M.H., Xin, Y., Gu, L.-P., et al. (2008) Inhibitory Effect of Ginsenoside Rg3 on Ovarian Cancer Metastasis. Chinese Journal of Medicine (English), 121, 1394-1397. https://doi.org/10.1097/00029330-200808010-00012
|
[40]
|
Lee, J.G., Mckinney, K.Q., Pavlopoulos, A.J., Park, J.H. and Hwang, S. (2015) Identification of Anti-Metastatic Drug and Natural Compound Targets in Isogenic Colorectal Cancer Cells. Journal of Proteomics, 113, 326-336. https://doi.org/10.1016/j.jprot.2014.10.009
|
[41]
|
Qin, Y., Zhang, Q., Lee, S., Zhong, W.L. and Zhou, H.G. (2015) Doxycycline Reverses Epithelial-to-Mesenchymal Transition and Suppresses the Proliferation and Metastasis of Lung Cancer Cells. Oncotarget, 6, 40667-40679. https://doi.org/10.18632/oncotarget.5842
|
[42]
|
Chang, C.J., Chao, C.H., Xia, W., Yang, J.Y. and Hung, M.C. (2011) p53 Regulates Epithelial-Mesenchymal Transition (EMT) and Stem Cell Properties through Modulating miRNAs. Nature Cell Biology, 13, 317-323. https://doi.org/10.1038/ncb2173
|
[43]
|
Thiery, J., Acloque, H., Huang, R.Y. and Nieto, M.A. (2009) Epithelial-Mesenchymal Transitions in Development and Disease. Cell, 139, 871-890. https://doi.org/10.1016/j.cell.2009.11.007
|
[44]
|
Lim, H.K., Bae, W., Lee, H.S. and Jung, J. (2014) Anticancer Activity of Marine Sponge Hyrtios sp. Extract in Human Colorectal Carcinoma RKO Cells with Different p53 Status. Journal of Biomedicine and Biotechnology, 2014, Article ID: 413575. https://doi.org/10.1155/2014/413575
|
[45]
|
Tian, L., Shen, D., Li, X., Shan, X., Wang, X., Yan, Q., et al. (2016) Ginsenoside Rg3 Inhibits Epithelial-Mesenchymal Transition (EMT) and Invasion of Lung Cancer by Down-Regulating FUT4. Oncotarget, 7, 1619-1632. https://doi.org/10.18632/oncotarget.6451
|
[46]
|
Kim, Y.J., et al. (2014) Stereospecific Effects of Ginsenoside 20-Rg3 Inhibits TGF-β1-Induced Epithelial-Mesenchymal Transition and Suppresses Lung Cancer Migration, Invasion and Anoikis Resistance. Toxicology, 322, 23-33. https://doi.org/10.1016/j.tox.2014.04.002
|
[47]
|
Liu, T., Zhao, L., Zhang, Y., Chen, W., Liu, D., Hou, H., et al. (2014) Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells. PLoS ONE, 9, e103887. https://doi.org/10.1371/journal.pone.0103887
|
[48]
|
Lee, J.M., Dedhar, S., et al. (2006) The Epithelial-Mesenchymal Transition: New Insights in Signaling, Development, and Disease. Journal of Cell Biology, 172, 973-981. https://doi.org/10.1083/jcb.200601018
|
[49]
|
Zavadil, J., Cermak, L., Sotonieves, N. and Böttinger, E.P. (2004) Integration of TGF-beta/Smad and Jagged1/Notch Signalling in Epithelial-to-Mesenchymal Transition. Embo Journal, 23, 1155-1165. https://doi.org/10.1038/sj.emboj.7600069
|
[50]
|
Attele, A.S., Wu, J.A. and Yuan, C.S. (1999) Ginseng Pharmacology: Multiple Constituents and Multiple Actions. Biochemical Pharmacology, 58, 1685-1693. https://doi.org/10.1016/S0006-2952(99)00212-9
|
[51]
|
Konoshima, T., Takasaki, M. and Tokuda, H. (1997) Antitumor-Promoting Activities of Ginsenoside Rg1 and Panax Notoginseng. Springer, Berlin. https://doi.org/10.1007/978-4-431-67017-9_47
|
[52]
|
Tie-Hua Z. (1994) Enhancing Effect of Ginsenoside Rg1 on LAK Cells Antitumor Activity in Vitro. Chinese Journal of Clinical Oncology, 21, 48-49.
|
[53]
|
Li, Q., Shi, S.L., Liu, Q.R., Tang, J., Song, J. and Liang, Y. (2008) Anticancer Effects of Ginsenoside Rg1, Cinnamic Acid, and Tanshinone IIA in Osteosarcoma MG-63 Cells: Nuclear Matrix Downregulation and Cytoplasmic Trafficking of Nucleophosmin. International Journal of Biochemistry & Cell Biology, 40, 1918-1929. https://doi.org/10.1016/j.biocel.2008.01.031
|
[54]
|
Yu, M., Yu, X., Guo, D., Yu, B., Li, L., Liao, Q., et al. (2015) Ginsenoside Rg1 Attenuates Invasion and Migration by Inhibiting Transforming Growth Factor-β1-Induced Epithelial to Mesenchymal Transition in HepG2 Cells. Molecular Medicine Reports, 11, 3167-3173. https://doi.org/10.3892/mmr.2014.3098
|
[55]
|
Liu, D., Liu, T., Zhao, L. and Xu, L. (2017) Ginsenoside Rg1 Regulating NF-(kappa)B to Block Hypoxia for Inducing EMT in Ovarian Cancer Cell SKOV3. Chinese Journal of Woman & Child Health Research, 28, 273-275+278.
|
[56]
|
Wang, P., Du, X., Xiong, M., Cui, J., Yang, Q., Wang, W., et al. (2016) Ginsenoside Rd Attenuates Breast Cancer Metastasis Implicating Derepressing Microrna-18a-Regulated Smad2 Expression. Scientific Reports, 6, Article No. 33709. https://doi.org/10.1038/srep33709
|
[57]
|
Yoon, J.H., Choi, Y.J., Cha, S.W. and Lee, S.G. (2012) Anti-Metastatic Effects of Ginsenoside Rd via Inactivation of MAPK Signaling and Induction of Focal Adhesion Formation. Phytomedicine International Journal of Phytotherapy & Phytopharmacology, 19, 284-292. https://doi.org/10.1016/j.phymed.2011.08.069
|
[58]
|
Guan, N., Huo, X., Zhang, Z., Zhang, S., Luo, J. and Guo, W. (2015) Ginsenoside Rh2 Inhibits Metastasis of Glioblastoma Multiforme through Akt-Regulated MMP13. Tumor Biology, 36, 1-7. https://doi.org/10.1007/s13277-015-3387-1
|
[59]
|
Jung, J.S., Ahn, J.H., Le, T.K., Kim, D.H., Kim, H.S. (2013) Protopanaxatriol Ginsenoside Rh1 Inhibits the Expression of Matrix Metalloproteinases and the in Vitro Invasion/Migration of Human Astroglioma Cells. Neurochemistry International, 63, 80-86. https://doi.org/10.1016/j.neuint.2013.05.002
|
[60]
|
Han, S., Jeong, A.J., Yang, H., Bin Kang, K., Lee, H., Yi, E.H., et al. (2016) Ginsenoside 20(S)-Rh2 Exerts Anti-Cancer Activity through Targeting IL-6-Induced JAK2/STAT3 Pathway in Human Colorectal Cancer Cells. Journal of Ethnopharmacology, 194, 83-90. https://doi.org/10.1016/j.jep.2016.08.039
|
[61]
|
Phi, L.T.H., Wijaya, Y.T., Sari, I., Yang, Y.G., Lee, Y.K. and Kwon, H.Y. (2018) The Anti-Metastatic Effect of Ginsenoside Rb2 in Colorectal Cancer in an EGFR/SOX2 Dependent Manner. Cancer Medicine, 7, 5621-5631. https://doi.org/10.1002/cam4.1800
|
[62]
|
Liu, D., Liu, T., Teng, Y., Chen, W., Zhao, L. and Li, X. (2017) Ginsenoside Rb1 Inhibits Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells by Regulating microRNA-25. Experimental & Therapeutic Medicine, 14, 2895-2902. https://doi.org/10.3892/etm.2017.4889
|
[63]
|
Park, T.Y., Park, M.H., Shin, W.C., Rhee, M.H., Seo, D.W., Cho, J.Y., et al. (2008) Anti-Metastatic Potential of Ginsenoside Rp1, a Novel Ginsenoside Derivative. Biological & Pharmaceutical Bulletin, 31, 1802. https://doi.org/10.1248/bpb.31.1802
|
[64]
|
Akao, T., Kanaoka, M. and Kobashi, K. (1998) Appearance of Compound K, a Major Metabolite of Ginsenoside Rb1 by Intestinal Bacteria, in Rat Plasma after Oral Administration—Measurement of Compound K by Enzyme Immunoassay. Biological & Pharmaceutical Bulletin, 21, 245-249. https://doi.org/10.1248/bpb.21.245
|
[65]
|
Zhang, K. and Li, Y. (2015) Effects of Ginsenoside Compound K Combined with Cisplatin on the Proliferation, Apoptosis and Epithelial Mesenchymal Transition in MCF-7 Cells of Human Breast Cancer. Pharmaceutical Biology, 54, 561-568. https://doi.org/10.3109/13880209.2015.1101142
|
[66]
|
Ha, G.H., Park, J.S. and Breuer, E.K.Y. (2013) TACC3 Promotes Epithelial-Mesenchymal Transition (EMT) through the Activation of PI3K/Akt and ERK Signaling Pathways. Cancer Letters, 332, 63-73. https://doi.org/10.1016/j.canlet.2013.01.013
|
[67]
|
Chia, S., Gandhi, S., Joy, A.A., Edwards, S., Gorr, M., Hopkins, S., et al. (2015) Novel Agents and Associated Toxicities of Inhibitors of the pi3k/Akt/mtor Pathway for the Treatment of Breast Cancer. Current Oncology, 22, 33-48. https://doi.org/10.3747/co.22.2393
|
[68]
|
Yang, J., Zeng, Z., Peng, Y., Chen, J., Pan, L. and Pan, D. (2014) IL-7 Splicing Variant IL-7δ5 Induces EMT and Metastasis of Human Breast Cancer Cell Lines MCF-7 and BT-20 through Activation of PI3K/Akt Pathway. Histochemistry & Cell Biology, 142, 401-410. https://doi.org/10.1007/s00418-014-1222-1
|
[69]
|
Peng, W.T., Sun, W.Y., Sun, J.C., Du, J.J. and Wei, W. (2018) Effects of Ginsenoside CK on Migration and Invasion of Human Hepatoma Cell Line HepG2. Chinese Pharmacology Bulletin, 34, 27-32.
|
[70]
|
Han, M.S., Han, I.H., Lee, D., An, J.M., Kim, S.N., Shin, M.S., et al. (2016) Beneficial Effects of Fermented Black Ginseng and Its Ginsenoside 20(S)-Rg3 against Cisplatin-Induced Nephrotoxicity in LLC-PK1 Cells. Journal of Ginseng Research, 40, 135-140. https://doi.org/10.1016/j.jgr.2015.06.006
|
[71]
|
Park, J.Y., Choi, P., Kim, T., Ko, H., Kim, H.K., Kang, K.S., et al. (2015) Protective Effects of Processed Ginseng and Its Active Ginsenosides on Cisplatin-Induced Nephrotoxicity: In Vitro and in Vivo Studies. Journal of Agricultural and Food Chemistry, 63, 5964-5969. https://doi.org/10.1021/acs.jafc.5b00782
|
[72]
|
Wang, J., Tian, L., Khan, M.N., Zhang, L., Chen, Q., Zhao, Y., et al. (2018) Ginsenoside Rg3 Sensitizes Hypoxic Lung Cancer Cells to Cisplatin via Blocking of NF-kappaB Mediated Epithelial-Mesenchymal Transition and Stemness. Cancer Letters, 415, 73-85. https://doi.org/10.1016/j.canlet.2017.11.037
|
[73]
|
Lee, C.K., Park, K.K., Chung, A.S. and Chung, W.Y. (2012) Ginsenoside Rg3 Enhances the Chemosensitivity of Tumors to Cisplatin by Reducing the Basal Level of Nuclear Factor Erythroid 2-Related Factor 2-Mediated Heme Oxygenase-1/NAD(P)H Quinone Oxidoreductase-1 and Prevents Normal Tissue Damage by Scavenging Cisplatin-Induced Intracellular Reactive Oxygen Species. Food and Chemical Toxicology, 50, 2565-2574. https://doi.org/10.1016/j.fct.2012.01.005
|
[74]
|
Tang, Y.C., Zhang, Y., Zhou, J., Zhi, Q., Wu, M.Y., Gong, F.R., et al. (2017) Ginsenoside Rg3 Targets Cancer Stem Cells and Tumor Angiogenesis to Inhibit Colorectal Cancer Progression in Vivo. International Journal of Oncology, 52, 127-138. https://doi.org/10.3892/ijo.2017.4183
|
[75]
|
Jiang, J., Yuan, Z., Sun, Y., Bu, Y., Li, W. and Fei, Z. (2017) Ginsenoside Rg3 Enhances the Anti-Proliferative Activity of Erlotinib in Pancreatic Cancer Cell Lines by Downregulation of EGFR/PI3K/Akt Signaling Pathway. Biomedicine & Pharmacotherapy, 96, 619-625. https://doi.org/10.1016/j.biopha.2017.10.043
|
[76]
|
Deng, S., Wong, C.K.C., Lai, H.C. and Wong, A.S.T. (2017) Ginsenoside-Rb1 Targets Chemotherapy-Resistant Ovarian Cancer Stem Cells via Simultaneous Inhibition of Wnt/beta-Catenin Signaling and Epithelial-to-Mesenchymal Transition. Oncotarget, 8, 25897-25914. https://doi.org/10.18632/oncotarget.13071
|
[77]
|
Nakata, H., Kikuchi, Y., Tode, T., Hirata, J., Kita, T., Ishii, K., et al. (1998) Inhibitory Effects of Ginsenoside Rh2 on Tumor Growth in Nude Mice Bearing Human Ovarian Cancer Cells. Japanese Journal of Cancer Research, 89, 733-740. https://doi.org/10.1111/j.1349-7006.1998.tb03278.x
|
[78]
|
Yun, U.J., Lee, J.H., Koo, K.H., Ye, S.K., Kim, S.Y., Lee, C.H., et al. (2013) Lipid Raft Modulation by Rp1 Reverses Multidrug Resistance via Inactivating MDR-1 and Src Inhibition. Biochemical Pharmacology, 85, 1441-1453. https://doi.org/10.1016/j.bcp.2013.02.025
|
[79]
|
Chian, S., Zhao, Y., Xu, M., Yu, X. and Yin, L. (2019) Ginsenoside Rd Reverses Cisplatin Resistance in Non-Small-Cell Lung Cancer A549 Cells by Downregulating the Nuclear Factor Erythroid 2-Related Factor 2 Pathway. Anti-Cancer Drugs, 30, 838-845. https://doi.org/10.1097/CAD.0000000000000781
|